Revolutionizing mRNA Cancer Therapy Delivery Researchers at Purdue University have unveiled a patent-pending, virus-mimicking platform called the LENN system, designed to enhance the stability and precision of messenger RNA (mRNA) therapies targeting cancer cells. In a field where delivery efficiency and targeted expression can determine treatment outcomes, LENN represents a compelling step forward for mRNA-based…